Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Company closed $22M financing to support randomized Phase 2b trial; IND cleared and study initiated; Interim results anticipated in late 2026; topline data expected in H2/2027 ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

Abscopal effect refers to the shrinkage or regression of metastatic tumours that are distant from the irradiated field.

A Northern Ireland mum has said being diagnosed with an incurable cancer just days after her daughter's first birthday "felt ...

After being diagnosed with an extremely rare form of cancer and being told he had 12 to 18 months to live, Alex Villalta ...

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...

New research shows resilience partially offsets financial toxicity and improves quality of life in patients with primary ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...

A federal inmate died of treatable colon cancer after waiting six months for an urgent colonoscopy. Medical neglect like this ...

Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation ...